CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX)

Historical Holders from Q2 2015 to Q3 2025

Symbol
CDTX on Nasdaq
CUSIP
171757107
Type / Class
Equity / Stock
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
6.16K
Holdings value
$300K
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
2
Number of buys
2
Average Value change %
+0%
Average buys %
+0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 6.16K $590K +$479 $95.78 2
2025 Q2 6.16K $300K +$300K $55.36 2
2024 Q3 0 $0 -$3.68K 0
2024 Q2 4K $3.68K -$211K $0.92 1
2024 Q1 235K $214K -$1.39M $0.92 7
2023 Q4 23.2M $18.4M -$664K $0.79 50
2023 Q3 24.1M $22.7M -$2.16M $0.94 52
2023 Q2 26.3M $29.7M -$1.15M $1.13 52
2023 Q1 27.1M $34.4M +$1.37M $1.27 52
2022 Q4 26.6M $20.1M -$163K $0.76 39
2022 Q3 27.1M $17.1M -$37K $0.63 38
2022 Q2 27.2M $13.3M -$1.66M $0.49 40
2022 Q1 30.3M $25.2M -$985K $0.83 39
2021 Q4 31.1M $39.5M +$12.4M $1.27 48
2021 Q3 18.4M $41.3M -$3.1M $2.24 48
2021 Q2 20M $40.5M -$3.28M $2.02 53
2021 Q1 21.3M $56.6M -$5.97M $2.66 62
2020 Q4 24M $48.1M -$6.74M $2.00 61
2020 Q3 24.1M $68.7M +$1.31M $2.85 64
2020 Q2 25.1M $92.7M +$12.1M $3.69 64
2020 Q1 22.4M $55.6M +$14.5M $2.48 51
2019 Q4 16.5M $63.3M +$3.48M $3.84 50
2019 Q3 14.5M $28.9M -$2.4M $2.00 34
2019 Q2 15.8M $26.5M +$2.15M $1.68 41
2019 Q1 16.1M $42.5M -$4.2M $2.65 49
2018 Q4 17.7M $41.5M -$4.94M $2.35 49
2018 Q3 17.3M $73.9M -$2.22M $4.40 59
2018 Q2 17.7M $89.8M +$21.2M $5.20 56
2018 Q1 13.3M $53.1M -$8.59M $4.00 58
2017 Q4 14.9M $102M +$13.5M $6.80 47
2017 Q3 11.2M $90.7M +$923K $8.10 40
2017 Q2 11.1M $83.4M -$1.71M $7.50 53
2017 Q1 11.4M $89.3M +$3.84M $7.80 51
2016 Q4 11.4M $119M +$22.4M $10.40 57
2016 Q3 7.88M $90.2M -$2.74M $11.45 51
2016 Q2 8.17M $84.2M -$7.11M $10.31 55
2016 Q1 8.82M $112M -$1.56M $12.70 42
2015 Q4 8.94M $153M +$3.28M $17.16 43
2015 Q3 6.42M $81.6M +$7.05M $12.72 44
2015 Q2 5.94M $83.2M +$67.2M $14.02 43